Market Cap

Aridis Pharmaceuticals, Inc. Market Capitalization:

$8,914

USD as of Jan. 1, 2026

business Aridis Pharmaceuticals, Inc. Company Profile

Aridis Pharmaceuticals, Inc. Main Stock Listing

NASDAQ: ARDS

Market Capitalization History of Aridis Pharmaceuticals, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Aridis Pharmaceuticals, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $8,914 100.00%
Jan. 1, 2025 $4,457 -99.85%
Jan. 1, 2024 $3.0 M -91.06%
Jan. 1, 2023 $33.2 M -34.81%
Jan. 1, 2022 $51.0 M -74.22%
Jan. 1, 2021 $197.8 M 1.59%
Jan. 1, 2020 $194.7 M -17.34%
Jan. 1, 2019 $235.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Aridis Pharmaceuticals, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Aridis Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NASDAQ: ARDS

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.